Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Kono M, Nakamura Y, Enomoto N, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Kobayashi T, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Inui N, Suda T, Nakamura H.
Kono M, et al. Among authors: miyashita k.
Respir Investig. 2019 Nov;57(6):552-560. doi: 10.1016/j.resinv.2019.07.003. Epub 2019 Aug 31.
Respir Investig. 2019.
PMID: 31477470